🇺🇸 FDA
Pipeline program

Two Anti-angiogenesis Drugs(Endostar and Thalidomide)

FirstPeoplesHHeFei

Phase 3 small_molecule active

Quick answer

Two Anti-angiogenesis Drugs(Endostar and Thalidomide) for Colorectal Neoplasms is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Colorectal Neoplasms
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials